PO
Poolbeg Pharma PLC
POLBF · OTC
$0.10 +0.00% (+$0.00)
Market Cap £54.2M
P/E Ratio -
Div. Yield -
ROE 53.90%
Piotroski F-Score Weak
1/9Valuation
21 /100
Expensive P/B 6.30x
P/E N/A
EV/FFO N/A
Growth
0 /100
Declining Book val. growth 22.29%
EPS growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor ROIC 73.60%
Asset turnover 0.00x
ROE 53.90%
Debt
100 /100
Low Debt/Equity 0.00x
Current ratio 6.17x
Int. coverage N/A
Stability
27 /100
Unstable Beta 1.81x
Profitable years 0
EPS volatility 37.15%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about POLBF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jeremy Skillington
Employees
15
Headquarters
London
Upcoming events
04 MAR
Earnings
Upcoming earnings report